This article is featured in O’Dwyer’s Oct. ’18 Healthcare PR Magazine. We encounter new challenges within the health communications sector nearly every day. Publications across [...]
To drive meaningful change in health in the UK is challenging, as I am sure it is across the world. It requires a clarity of purpose and evidence, a wide range of engaged stakeholders and [...]
With the authorization of $1.8 billion in funding for the Cancer Moonshot over 7 years, we’ve seen both hope and hype around how we accelerate cancer research to make more treatments available to [...]
Last week, I had the opportunity to attend MassBio & Sanofi Genzyme’s event entitled “No Borders: A Conversation on Global Humanitarian Programs.” The overarching theme resided in the notion [...]
For nearly every known disease or condition, there also exists a core group of patients and caregivers who care passionately about it: pushing for research, asking hard questions about new [...]
Patients and advocacy groups may be one step closer to increasing the strength of their voices in the development of new treatments. A bill designed to spur biomedical innovation and place [...]
If you live in the Northeast and are active on social, by now you’ve seen it – a 30-second to 1 minute selfie video that starts with a quick preamble and culminates in the video subject’s [...]
Picture this – your company just implemented an enormously successful breast cancer awareness program in the United States. Your leadership team is so thrilled they’ve asked you to [...]
My work in healthcare public relations has influenced how I read news—I’m always analyzing media trends, guessing which stories were placed by PR people and reading articles looking for [...]
Recently, representatives of leading pharmaceutical companies gathered in London at the 2011 Pharma MedComms World conference to discuss major challenges in conducting medical communications in [...]